Recent posts

TypePostAuthorRepliesLast updated
Blog entryACTA: the new institution James Love014 hours 37 min ago
Blog entryPhRMA's asks regarding special 301, drug pricing and reimbursement KEI Staff018 hours 49 min ago
Blog entryEU proposes ACTA require criminal sanctions for inciting, aiding and abetting infringements James Love01 day 55 min ago
Blog entryIndian NGOs confront GWU Law School efforts to push maximalist IPR norms in India Judit Rius02 days 17 hours ago
Blog entryVideo of Google, DC January 11, 2010 debate on ACTA Staff02 days 20 hours ago
Blog entryAri Emanuel: Did he mention lobbying the President or the Vice President? James Love03 days 13 hours ago
Book pageMedical professional and patient group funding by drug and medical device companies James Love03 days 14 hours ago
PageUS Patent and Trademark Office (USPTO) FOIA requests James Love03 days 15 hours ago
Blog entry633 to 13, EU Parliament votes to make ACTA public, and more sensitive to civil liberties and consumer protection James Love06 days 11 hours ago
Blog entryDay after European Parliament votes against ACTA, Obama expresses support James Love06 days 13 hours ago
Blog entryThe USPTO-Pfizer collaboration to change India's laws on patents and test data Malini Aisola11 week 13 hours ago
Blog entryEuropean Committee for Interoperable Systems (ECIS) intervention on standards and patents at WIPO SCP 14 thiru21 week 1 day ago
Blog entryJeffrey Kindler rewarded by Pfizer for his influence with governments KEI Staff01 week 2 days ago
Blog entryFOIA document: In 2007, US Ambassador Ralph Boyce was pleased that Abbott withdrew life saving drugs from market in Thailand James Love01 week 3 days ago
PagePhRMA's revolving door James Love01 week 5 days ago
Blog entryUSTR pressures Taiwan on pricing and reimbursement of pharmaceuticals and medical devices James Love01 week 5 days ago
Book pageTimeline: Addressing Copyright Related Barriers to Overcoming Reading Disabilities Manon Ress11 week 6 days ago
Blog entrySix Myths about the treaty for people with disabilities that should be debunked next week? Manon Ress11 week 6 days ago
Blog entryKEI looks at USTR letter to Wyden, and conflicts between ACTA and patent reform James Love01 week 6 days ago
Blog entrySenator Leahy, asleep at the switch on ACTA provisions on patent damages James Love01 week 6 days ago
Blog entryBilly Tauzin's 2008 compensation from PhRMA was $4,476,157 KEI Staff02 weeks 14 hours ago
Blog entryPhRMA's grants to US organizations in 2008 KEI Staff32 weeks 14 hours ago
PageThe U.S. Special 301 Reports, 1989 to 2010 James Love02 weeks 16 hours ago
Blog entryPhRMA pushes for data exclusivity in 2010 Special 301 comments Malini Aisola12 weeks 19 hours ago
Blog entryKEI notes on the EU leak of the ACTA text James Love02 weeks 2 days ago